Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from November 11 to November 30, 2013, with the report signed on December 12, 2013. The filing discloses transactions in securities and derivatives by the Company's Group, Board of Directors, and Management in compliance with Article 11 of CVM Instruction # 358/2002. This reporting window coincides with the commencement of trading for Ambev S.A. shares and ADRs on the BM&FBOVESPA and NYSE, respectively, following a Stock Swap Merger with Companhia de Bebidas das Américas.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly a disclosure of insider and related-party securities transactions.
| Category | Security Type | Initial Balance (Qty) | Transactions (Qty) | Final Balance (Qty) | Ownership % |
|---|---|---|---|---|---|
| Management | Common Shares | 17,820,650 | (3,455) Sell | 17,817,195 | 0.1138% |
| Management | Common ADRs | 8,749,435 | 0 | 8,749,435 | 0.0559% |
| Group & Related Persons | Common Shares | 11,219,706,065 | 18,855 Buy | 11,219,721,465 | 71.6339% |
| Fiscal Council | Common Shares | 6,825 | 0 | 6,825 | 0.0000% |
Material Changes
The primary material change disclosed is the Stock Swap Merger approved on July 30, 2013, where Companhia de Bebidas shareholders received five Ambev S.A. common shares for each Companhia de Bebidas share. Consequently, trading of the predecessor entity ceased on November 8, 2013, and Ambev S.A. began trading on November 11, 2013. The "Initial Balance" figures in this report reflect holdings adjusted by this 5:1 exchange ratio.
- Management Activity: A sale of 3,455 common shares occurred on November 27 via J.P. Morgan at a price of R$ 17.31 per share, totaling R$ 59,806.05.
- Group Activity: The Group and related persons executed a buy transaction of 18,855 shares on November 28 at a price of R$ 0.00 (likely an exchange or non-cash transaction).
Guidance, Outlook, and Risks
The filing text does not provide financial guidance, future outlook, management commentary on operations, or specific risk factors. The document is limited to regulatory compliance regarding securities transactions.
Investor Verification Checklist
- Verify the impact of the 5:1 Stock Swap Merger on historical share counts and ownership percentages.
- Confirm the trading commencement date of November 11, 2013, for Ambev S.A. on the NYSE and BM&FBOVESPA.
- Review the specific nature of the "Buy" transaction by the Group at R$ 0.00 to determine if it was a non-cash exchange.
- Check subsequent filings for actual financial performance (revenue, EBITDA) as this 6-K contains no operational data.